Delivery Order SPE2DB22D3501-SPE2DB26FTK60
- Not listed
- The Defense Logistics Agency awarded a $21,827.40 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Tibsovo 250 mg tablets (60-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion deadline of September 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is performing the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $21,827.41 to AmerisourceBergen Drug Corp for TIBSOVO 250 mg tablets (60-count units) on November 6, 2025, with completion scheduled for December 1, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a $21,827.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of TIBSOVO 250 mg on August 7, 2025, with completion scheduled for August 28, 2025. This non-set-aside award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on November 4, 2025, for TIBSOVO 250 mg tablets (60-count supply) with a firm fixed price ceiling value of $21,827.41. The contract is scheduled for completion by November 26, 2025. This is a competitively awarded, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $21,827.40 delivery order to AmerisourceBergen Drug Corp for 60 tablets of TIBSOVO 250 mg, a pharmaceutical product used in cancer treatment. This competitive, non-set-aside contract was awarded on June 3, 2025, with an ultimate completion date of June 25, 2025, and represents a firm fixed price delivery order. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of TIBSOVO 250 mg, a pharmaceutical product used in oncology treatment. This firm fixed-price delivery order, valued at $21,827.40, was competitively awarded without set-aside provisions and is scheduled for completion by May 14, 2025. The order was placed on April 23, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 28, 2025, by the Defense Logistics Agency to supply 60 tablets of Tibsovo 250 mg, a prescription medication used in oncology treatment. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $43,654.80 and is scheduled for completion by October 20, 2025. The contract contains no set-aside designation and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distributor. The $19,882.84 fixed-price delivery order is for the supply of the prescription medication Tibsovo (ivosidenib) 250 mg tablets. This contract is not set aside for any particular business size or type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TIBSOVO 250 MG TABLET 60S, a prescription medication, with a total ceiling value of $21,827.40 and a period of performance through July 22, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
- The Defense Logistics Agency Troop Support Medical awarded a $19,482 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 250 mg tablets of TIBSOVO. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 60 tablets of the specified medication to a location in Conshohocken, Pennsylvania, with performance required between July 10-31, 2023. No additional details were provided regarding major subcontractors or a potential set-aside designation. The...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTK60Delivery Order
The Defense Logistics Agency awarded a $21.8K delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Tibsovo (ivosidenib) 250 mg tablets in a quantity of 60 units. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The contract is set to be completed by December 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a comprehensive $1 billion IDC with DLA through December 2026, which serves as the global pharmaceutical support vehicle for this delivery order. The parent contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. Through this contract structure, AmerisourceBergen provides critical pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The Tibsovo delivery fulfills oncology medication needs within the company's extensive portfolio of therapeutic products supporting military and veteran healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.8k | 11/6/25 |